EU Authorizes Use of Adapted Vaccine for COVID-19 Variant :

The European Commission has authorized an updated COVID-19 vaccine from Pfizer/BioNtech to be used in EU countries' vaccination campaigns this autumn to target the dominant Omicron XBB.1.5 variant.

Related Keywords

Germany , Brussels , Bruxelles Capitale , Belgium , German , David Evans , Julia Payne , Pfizer , European Centre For Disease Prevention , European Medicines Authority , European Commission , European Centre , Disease Prevention , Covid 19 Vaccine , Coronavirus Vaccine , Covid 19 Omicron Variant , Ovid 19 Omicronb 1 529 Variant , Ovid 19b 1 529 Variant , Ars Cov 2b 1 529 Variant , Ars Cov 2 Omicronb 1 529 Variant , Ars Cov 2 Omicron Variant , Ars Cov 2 Variantb 1 529 , Europe , European , Vaccine , Immunizations , Vaccination , Coronavirus , 019 Novel Coronavirus , 019 Ncov , Uhan Coronavirus , Uman Coronavirus Hku1 , Um ,